雜志介紹

Clinical And Translational Medicine雜志介紹

《Clinical And Translational Medicine》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱臨床和轉(zhuǎn)化醫(yī)學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為7.9，最新CiteScore 指數(shù)為15.9。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• In-frame deletion of SMC5 related with the phenotype of primordial dwarfism, chromosomal instability and insulin resistance

  Author: Zhu, Wenjiao; Shi, Yuanping; Zhang, Changrun; Peng, Yajie; Wan, Yueyue; Xu, Yue; Liu, Xuemeng; Han, Bing; Zhao, Shuangxia; Kuang, Yanping; Song, Huaidong; Qiao, Jie

• c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming

  Author: Zhang, Qiang; Cui, Kaisa; Yang, Xiaoya; He, Qilang; Yu, Jing; Yang, Li; Yao, Gang; Guo, Weiwei; Luo, Zhanhao; Liu, Yugeng; Chen, Yuan; He, Zhen; Lan, Ping

• Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long-chain acyl-coenzyme A synthase 5

  Author: Zhang, Linlin; Liu, Xuanqi; Liu, Yifei; Yan, Furong; Zeng, Yiming; Song, Yuanlin; Fang, Hao; Song, Dongli; Wang, Xiangdong

• Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis

  Author: Zhang, Hao; Wang, Yanghanzhao; Qu, Mengdi; Li, Wenqian; Wu, Dan; Cata, Juan P. P.; Miao, Changhong

英文介紹

Clinical And Translational Medicine雜志英文介紹

Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal is focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.